Trending News
News
News
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
News
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
News
Envigo Invests in Science and Technology Advisory Group
STAG will act as an internal funding body for promising research; develop new assays and technologies alongside customers, and attract the next generation of scientists.
News
NuSirt Biopharma, OWL Metabolomics Partner
Partnership aims to develop novel diagnostic tools for ongoing drug evaluation trials for NuSirt’s fatty liver drug research candidate, NS-0200.
News
BLRX Announces In-licensing of Novel Treatment for Liver Failure Conditions
Therapeutic compound is second project in-licensed under strategic collaboration with Novartis for screening and development of novel drug candidates.
News
Genomics England, GenomOncology LLC Partner
Partnership aims to utilise the GO KMS as a tool for clinical reporting enablement.
News
Basilea, Asahi Kasei Partner
Collaboration aims to develop and commercialize isavuconazole in Japan.
News
Veristat, Aegerion Partner
Partnership aims to develop and commercialize innovative therapies for patients with debilitating rare diseases.
News
Gyros Establishes Dedicated Office in Japan
The dedicated Japan team provides sales, applications and service support in Japan for the Company’s Gyros’ immunoassay business.
News
Affimer Therapeutics Yield Positive Results
Avacta announces positive results from first preclinical in-vivo studies of Affimer therapeutics.
Advertisement